Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
Biggi A, Bergesio F, Chauvie S, Bianchi A, Menga M, Fallanca F, Hutchings M, Gregianin M, Meignan M, Gallamini A. Biggi A, et al. Among authors: fallanca f. Q J Nucl Med Mol Imaging. 2021 Dec;65(4):410-415. doi: 10.23736/S1824-4785.17.02993-4. Epub 2017 Jul 27. Q J Nucl Med Mol Imaging. 2021. PMID: 28750493
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation.
Dodero A, Crocchiolo R, Patriarca F, Miceli R, Castagna L, Ciceri F, Bramanti S, Frungillo N, Milani R, Crippa F, Fallanca F, Englaro E, Corradini P. Dodero A, et al. Among authors: fallanca f. Cancer. 2010 Nov 1;116(21):5001-11. doi: 10.1002/cncr.25357. Cancer. 2010. PMID: 20665491 Free article.
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
Gallamini A, Patti C, Viviani S, Rossi A, Fiore F, Di Raimondo F, Cantonetti M, Stelitano C, Feldman T, Gavarotti P, Sorasio R, Mulè A, Leone M, Rambaldi A, Biggi A, Barrington S, Fallanca F, Ficola U, Chauvie S, Gianni AM; Gruppo Italiano Terapie Innovative nei Linfomi (GITIL). Gallamini A, et al. Among authors: fallanca f. Br J Haematol. 2011 Mar;152(5):551-60. doi: 10.1111/j.1365-2141.2010.08485.x. Epub 2010 Dec 20. Br J Haematol. 2011. PMID: 21166786 Free article. Clinical Trial.
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma.
Fallanca F, Picchio M, Crivellaro C, Mapelli P, Samanes Gajate AM, Sabattini E, Gianolli L, Messa C. Fallanca F, et al. Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):207-9. doi: 10.1016/j.remn.2012.03.002. Epub 2012 Apr 26. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 22980128
WIDEN: A tool for medical image management in multicenter clinical trials.
Chauvie S, Biggi A, Stancu A, Cerello P, Cavallo A, Fallanca F, Ficola U, Gregianin M, Guerra UP, Chiaravalloti A, Schillaci O, Gallamini A. Chauvie S, et al. Among authors: fallanca f. Clin Trials. 2014 Jun;11(3):355-361. doi: 10.1177/1740774514525690. Clin Trials. 2014. PMID: 24711610
57 results